霸菱亚洲从东京海上购入日本制药商

星期一, 2014年11月17日

(AVCJ by Tim Burroughs) - Baring Private Equity Asia has agreed to buy Japan-based Bushu Pharmaceuticals from Tokio Marine Capital at an enterprise valuation of JPY77.3 billion ($670 million).

According to AVCJ Research, Tokio Marine-managed TMCAP2005 - a JPY32.6 billion fund raised in 2005 - purchased Bushu from Shionogi & Co. for JPY8.56 billion (then $93 million) in 2010. Baring Asia's acquisition represents the largest healthcare M&A deal announced in Japan so far this year. It is also the largest secondary buyout in over two years, and the ninth-biggest on record.

View full article here